Cell Surface Markers 2011: US, Europe, Japan Forecasts by Test, Market Segment and Country
NEW YORK, Sept. 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Cell Surface Markers 2011: US, Europe, Japan Forecasts by Test, Market Segment and Country
http://www.reportlinker.com/p0365379/Cell-Surface-Markers-2011-US-Europe-Japan-Forecasts-by-Test-Market-Segment-and-Country.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.
This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.
The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 120 pages and 15 tables
Table of Contents
I. Introduction
II. Worldwide Market and Technology Overview
A. Lymphocyte Subclassification CD4/CD8/CD34
Instrumentation and
Reagent Test Kits
BD FACS Count
Beckman Coulter VCS
T Cells Diagnostics TRAx
B. Other Cell Markers
C. Instrumentation Review
1. Hematology Analyzers
a. Overview
Electrical Aperture-Impedance
Analyzers
Light Scatter Analyzers
b. System Review
Abbott Cell-Dyn 3000
Abbott Cell-Dyn 3200
Abbott Cell-Dyn 3500
Abbott Cell-Dyn 3700
Abbott Cell-Dyn Ruby
Abbott Cell-Dyn Sapphire
Abbott Cell-Dyn Emerald
Beckman Coulter HmX
Beckman Coulter LH 500
Beckman Coulter LH 750
Beckman Coulter LH 780
Beckman Coulter LH 1500
Beckman Coulter STKS
Beckman Coulter UniCell DxH 800
Horiba ABX Helios LMG/5DIFF
Horiba ABX Pentra Series
Siemens ADVIA/H Series
Siemens Advia 120
Siemens Advia 2120i
Sysmex XE-2100
Sysmex XE-5000
Sysmex XE-AlphaN
Sysmex HST-N
Sysmex NE-8000
Sysmex SE-9000
Sysmex XT Series
2. Flow Cytometers
a. Introduction
b. System Overview
Beckman Coulter Epics Profile
Beckman Coulter Epics XL
BD FACSadvantage
BD FACSAria III
BD FACScan
BD FACSCanto II
BD FACSCalibur
BD FACSCount
BD Influx
BD FACStar Series
BD FACSort
BD FACStrak
BD FACS Vantage
Beckman Coulter Epics Elite ESP
Beckman Coulter Epics Elite Analyzer
Beckman Coulter Epics C
Beckman Coulter FC 500 Series
Beckman Coulter Vi-CELL XR
D. Current Market Needs and Future Demand for Hematology Analyzers
E. Reagents and Controls
F. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
III. France : Forecasts by Test and Market Segment
IV. Germany : Forecasts by Test and Market Segment
V. Italy : Forecasts by Test and Market Segment
VI. Japan : Forecasts by Test and Market Segment
VII. Spain : Forecasts by Test and Market Segment
VIII. U.K. : Forecasts by Test and Market Segment
IX. U.S. : Forecasts by Test and Market Segment
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized Testing Markets
1. Four Marketing Approaches
2. Product Complexity Factor
3. Customer Preference Factor
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
Abbott
Beckman Coulter
Becton Dickinson
Bio-Rad
DakoCytomation
Horiba
Iris
J&J Diagnostics
Nihon Kohden
Roche
Siemens
Sysmex
XIII. Appendix: Major Universities and Research
Centers Developing Hematology/Flow Cytometry
Technologies and Applications
List of Tables
France, Hospital Laboratories Estimated Cell Surface Marker Test Volume
France, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Germany, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Italy, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Italy, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Japan, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Japan, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Spain, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Spain, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Spain, Ambulatory Care Center Estimated Cell Surface Marker Test Volume
U.K., Hospital Laboratories Estimated Cell Surface Marker Test Volume
U.K., Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
U.S., Hospital Laboratories Estimated Cell Surface Marker Test Volume
U.S., Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
U.S., Physician Office Laboratories Estimated Cell Surface Marker Test Volume
To order this report:
In Vitro Diagnostic Industry: Cell Surface Markers 2011: US, Europe, Japan Forecasts by Test, Market Segment and Country
In Vitro Diagnostic Business News
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article